RÉSUMÉ
OBJECTIVE: To establish the sources of lymphocytosis in children living in ecologically unfavorable conditions after the Chornobyl Nuclear Power Plant accident aiming the high risk group formation for oncohematological diseases among the children's population. MATERIALS AND METHODS: The 226 children with lymphocytosis were surveyed. The of child's life history and kind of somatic morbidity were considered. Quantitative and qualitative parameters of blood cells, biochemical indices including immunoglobulins (A, M, G), circulating immune complexes, phagocytosis indices were assayed. RESULTS: Children with lymphocytosis were more often born with a high bodyweight, they demonstrated manifestations of constitutional lymphatism, lymphadenopathy and more often had respiratory infections. Quantitative and qualitative changes of hemopoietic elements depended on a type of a disease. Activation of lipid peroxidation, dysimmunoglobulinemia and increased level of circulating immune complexes were revealed. Treatment and preventive actions promoted normalization of hemogram indices in 58% of children surveyed. CONCLUSIONS: The abnormalities in immune indices, activated lipid peroxidation in membranes of hemopoietic elements, and manifestations of granulocytopoietic disorders were established it children with lymphocytosis. Therefore these children can be attributed tot the group of increased risk on oncohematological disease.
Sujet(s)
Accident nucléaire de Tchernobyl , Exposition environnementale/analyse , Hyperlymphocytose/épidémiologie , Hyperlymphocytose/étiologie , Adolescent , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Exposition environnementale/effets indésirables , Humains , Immunoglobulines/sang , Peroxydation lipidique , Numération des lymphocytes , Hyperlymphocytose/sang , Hyperlymphocytose/prévention et contrôle , Granulocytes neutrophiles/cytologie , Granulocytes neutrophiles/immunologie , Phagocytose/immunologie , Polluants radioactifs/effets indésirables , Polluants radioactifs/analyse , UkraineRÉSUMÉ
Compelling evidence suggests that vitamin D3 insufficiency may contribute causally to multiple sclerosis (MS) risk. Experimental autoimmune encephalomyelitis (EAE) research firmly supports this hypothesis. Vitamin D3 supports 1,25-dihydroxyvitamin D3 (1,25-[OH]2D3) synthesis in the CNS, initiating biological processes that reduce pathogenic CD4+ T cell longevity. MS is prevalent in Sardinia despite high ambient UV irradiation, challenging the vitamin D-MS hypothesis. Sardinian MS patients frequently carry a low Ifng expresser allele, suggesting that inadequate IFN-γ may undermine vitamin D3-mediated inhibition of demyelinating disease. Testing this hypothesis, we found vitamin D3 failed to inhibit EAE in female Ifng knockout (GKO) mice, unlike wild-type mice. The two strains did not differ in Cyp27b1 and Cyp24a1 gene expression, implying equivalent vitamin D3 metabolism in the CNS. The 1,25-(OH)2D3 inhibited EAE in both strains, but 2-fold more 1,25-(OH)2D3 was needed in GKO mice, causing hypercalcemic toxicity. Unexpectedly, GKO mice had very low Vdr gene expression in the CNS. Injecting IFN-γ intracranially into adult mice did not increase Vdr gene expression. Correlating with low Vdr expression, GKO mice had more numerous pathogenic Th1 and Th17 cells in the CNS, and 1,25-(OH)2D3 reduced these cells in GKO and wild-type mice without altering Foxp3+ regulatory T cells. Thus, the Ifng gene was needed for CNS Vdr gene expression and vitamin D3-dependent mechanisms that inhibit EAE. Individuals with inadequate Ifng expression may have increased MS risk despite high ambient UV irradiation because of low Vdr gene expression and a high encephalitogenic T cell burden in the CNS.
Sujet(s)
Calcitriol/physiologie , Encéphalomyélite auto-immune expérimentale/immunologie , Régulation de l'expression des gènes/immunologie , Interféron gamma/physiologie , Hyperlymphocytose/prévention et contrôle , Sclérose en plaques/immunologie , Récepteur calcitriol/génétique , Sous-populations de lymphocytes T/immunologie , Animaux , Calcitriol/génétique , Modèles animaux de maladie humaine , Évolution de la maladie , Encéphalomyélite auto-immune expérimentale/étiologie , Encéphalomyélite auto-immune expérimentale/anatomopathologie , Femelle , Interféron gamma/biosynthèse , Interféron gamma/déficit , Hyperlymphocytose/immunologie , Hyperlymphocytose/anatomopathologie , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Sclérose en plaques/étiologie , Sclérose en plaques/anatomopathologie , Récepteur calcitriol/biosynthèse , Facteurs de risque , Sous-populations de lymphocytes T/métabolisme , Sous-populations de lymphocytes T/anatomopathologieRÉSUMÉ
The current screening for eligibility of unrelated volunteer marrow donors comprises a complete clinical check-up, a blood CBC and serum protein immunoelectrophoresis. This allows to eliminate acute leukemias, myeloproliferative and myelodysplastic disorders, myelomas and MGUS. To date, the risk of transmission of chronic lymphocytic leukemia (CLL) disease is only evaluated by the clinical evaluation and CBC. We report here the case of a CLL-type MBL disease occurring in a 12-year-old boy after unrelated BMT. Deep biological investigations, as Immunophenotyping, cytogenetic and molecular biology allow us to determine the donor origin of the CLL clone. In 2010, 14.2% donor (105/737) for unrelated hematopoietic stem cell transplantation were over 45y. It is currently estimated (USA) that 1 in 210 men and women will be diagnosed with CLL during their lifetime. Given the long asymptomatic phase of CLL, this raises the case for a detection strategy analog to that used for MGUS and myeloma through serum protein electrophoresis. This case-report, to our knowledge, of a CLL-type MBL unrelated donor-to-recipient transmission through BMT raises ethical and practical questions, such as the proper information about disease transmission risk. The cost-effectiveness of a systematic peripheral blood Immunophenotyping in donors elder than 40y at time of stem cell donation should be evaluated.
Sujet(s)
Transplantation de moelle osseuse/effets indésirables , Transplantation de moelle osseuse/normes , Leucémie chronique lymphocytaire à cellules B/étiologie , Leucémie chronique lymphocytaire à cellules B/prévention et contrôle , Hyperlymphocytose/étiologie , Hyperlymphocytose/prévention et contrôle , Donneurs non apparentés , Adulte , Séquence nucléotidique , Enfant , Femelle , Cytométrie en flux , Protéines de fusion bcr-abl/génétique , Réarrangement des gènes des lymphocytes B , Transplantation de cellules souches hématopoïétiques/effets indésirables , Humains , Immunophénotypage , Mâle , Contrôle de qualitéRÉSUMÉ
AIM: To evaluate clinical, biological and immunological features of patients with increased duodenal intraepithelial lymphocytes (IELs), and its relation to Helicobacter pylori (HP) and coeliac disease (CD). METHODS: We have studied all patients accrued over a 4-year period with increased duodenal IELs. Those patients were recalled for biological and immunological evaluation and a second endoscopy. RESULTS: Twenty-three from a total of 639 patients were identified and 17 of them were included in the study. The median duodenal IEL count was 59 per 100 epithelial cells. Twelve (71%) patients were HP+; eight of them received HP eradication. At the second endoscopy the duodenal IEL count was significantly lower 2 months after HP eradication (73 versus 28), while the IEL count was unchanged in those patients seronegative for HP (n = 5) or those in whom it was not eradicated (n = 4) (55 versus 55). No patient had coeliac antibodies, four expressed HLA-DQ2, lower than in the general population, and the prevalence of CD was 2% (12/639 patients). CONCLUSION: In some cases an increased duodenal IEL count may be due to an inappropriate host response to HP. HP screening and eradication should be considered before recommending a gluten-free diet.
Sujet(s)
Antibactériens/usage thérapeutique , Duodénum/effets des médicaments et des substances chimiques , Infections à Helicobacter/traitement médicamenteux , Helicobacter pylori/effets des médicaments et des substances chimiques , Hyperlymphocytose/prévention et contrôle , Biopsie , Maladie coeliaque/complications , Maladie coeliaque/immunologie , Numération cellulaire , Duodénum/microbiologie , Duodénum/anatomopathologie , Endoscopie gastrointestinale , Épithélium/effets des médicaments et des substances chimiques , Épithélium/microbiologie , Épithélium/anatomopathologie , Femelle , Antigènes HLA-DQ/immunologie , Chaines bêta des antigènes HLA-DQ , Antigène HLA-DR4/immunologie , Infections à Helicobacter/complications , Infections à Helicobacter/microbiologie , Humains , Lymphocytes/anatomopathologie , Hyperlymphocytose/étiologie , Hyperlymphocytose/anatomopathologie , Mâle , Estomac/effets des médicaments et des substances chimiques , Estomac/microbiologie , Estomac/anatomopathologieRÉSUMÉ
PURPOSE: To study the association of polyclonal B-cell lymphocytosis with binucleated lymphocytes with clinical manifestations suggesting the existence of an immunodeficiency, to evaluate the effect of cigarette smoking on this 'benign lymphoid proliferation', to analyze the clonality of lymphocytes, to determine the levels of immunoglobulins (Ig) G, A, M. METHODS: Description and analysis of the results obtained in four patients and literature review. RESULTS: Polyclonal B-cell lymphocytosis is associated with both a decrease in IgA and IgG and an increase in IgM. Recurrent infectious episodes (bronchitis) were observed in two patients. Transient smoking cessation allowed a decrease in lymphocytosis and IgM levels in two patients. No hematological malignancy occurred during the follow-up, while biological abnormalities persisted. CONCLUSION: Persistent polyclonal B-cell lymphocytosis may be associated with minor clinical features of immunodeficiency. Smoking cessation may sometimes lead to a decrease in lymphocytosis and IgM.
Sujet(s)
Lymphocytes B , Déficit en IgA/sang , Déficit en IgA/étiologie , Déficit en IgG/sang , Déficit en IgG/étiologie , Immunoglobuline M/sang , Hyperlymphocytose/sang , Hyperlymphocytose/étiologie , Fumer/effets indésirables , Adulte , Sujet âgé , Lymphocytes B/ultrastructure , Bronchite/étiologie , Femelle , Antigène HLA-DR7/génétique , Humains , Déficit en IgA/diagnostic , Déficit en IgA/prévention et contrôle , Déficit en IgG/diagnostic , Déficit en IgG/prévention et contrôle , Numération des lymphocytes , Hyperlymphocytose/diagnostic , Hyperlymphocytose/prévention et contrôle , Mâle , Adulte d'âge moyen , Pronostic , Récidive , Arrêter de fumer , Prévention du fait de fumerRÉSUMÉ
OBJECTIVE: Purpose of the study was clinical evaluation of thymopentin and interleukins in the changes of immunity due to anesthesia and surgical operation. DESIGN: After randomization the patients were divided into four groups according to starter type (thiopental or propofol) and immunological pre-treatment (tymopentin or saline of control group) administered for three days before and two days after operation. SETTING AND PATIENTS: The study was effected on 40 patients undergoing venous vascular surgery in operating rooms of Medical School of University of Genoa. MEASUREMENT: At pre-established times (basal, before and after induction, recovery and 72 postoperative hours) were measured some immunological data (plasmatic concentrations of red blood cells, white blood cells, lymphocyte cells, antibodies, complement analysis, interleukins 1 and 2). RESULTS: The results show a depression of immunity with hypoleucocistosis and hyperlymphocytosis due to surgical trauma or to anesthesia drugs. CONCLUSIONS: Pre-treatment with thymopentin no change perioperative immunity and the role of interleukins isn't clear; the immunological depression is the same in thiopental of propofol groups.
Sujet(s)
Anesthésie/effets indésirables , Interleukine-1/sang , Interleukine-2/sang , Leucopénie/étiologie , Hyperlymphocytose/étiologie , Complications postopératoires/immunologie , Propofol/effets indésirables , Thiopental/effets indésirables , Thymopentine/usage thérapeutique , Adulte , Sujet âgé , Méthode en double aveugle , Femelle , Humains , Leucopénie/prévention et contrôle , Hyperlymphocytose/prévention et contrôle , Mâle , Adulte d'âge moyen , Prémédication , Thymopentine/administration et posologie , Varices/chirurgieSujet(s)
Maladies des bovins/transmission , Hyperlymphocytose/médecine vétérinaire , Lymphome malin non hodgkinien/médecine vétérinaire , Animaux , Anticorps antiviraux/analyse , Antigènes viraux , Bovins , Maladies des bovins/immunologie , Maladies des bovins/prévention et contrôle , Vecteurs de maladies , Immunodiffusion , Virus de la leucémie bovine , Hyperlymphocytose/congénital , Hyperlymphocytose/embryologie , Hyperlymphocytose/immunologie , Hyperlymphocytose/prévention et contrôle , Hyperlymphocytose/transmission , Lymphome malin non hodgkinien/congénital , Lymphome malin non hodgkinien/embryologie , Lymphome malin non hodgkinien/immunologie , Lymphome malin non hodgkinien/prévention et contrôle , Lymphome malin non hodgkinien/transmission , Lait , Dosage radioimmunologiqueSujet(s)
Maladies des bovins/prévention et contrôle , Hyperlymphocytose/médecine vétérinaire , Lymphome malin non hodgkinien/médecine vétérinaire , Animaux , Anticorps antiviraux/immunologie , Antigènes viraux/immunologie , Bovins , Maladies des bovins/immunologie , Femelle , Immunodiffusion , Virus de la leucémie bovine/immunologie , Hyperlymphocytose/immunologie , Hyperlymphocytose/prévention et contrôle , Lymphome malin non hodgkinien/immunologie , Lymphome malin non hodgkinien/prévention et contrôle , GrossesseRÉSUMÉ
Naturally occurring Trypanosoma theileri infection was studied in two cattle herds. Herd A was a dairy herd of approximately 250. Herd B was an isolated herd of 32 and contained both dairy and beef breeds. Blood samples were collected from all animals in Herd A during July and August on two successive years. Samples were collected from Herd B at monthly intervals. Total leukocyte and differential counts packed cell volume determinations, and trypanosome cultures were made on each sample. Infection was detected in all age groups between seven months and fifteen years but it was rare in calves. Infected animals were not consistently positive for trypanosomes on consecutive blood cultures and there was considerable variation between infected individuals. Positive cultures were usually obtained from some animals while others were positive intermittently. No correlation was found between trypanosome isolations and the season of the year.A correlation was found between trypanosome isolation and lymphocytosis. Of the 920 blood samples examined, approximately one in every five trypanosome positive samples had lymphocyte levels in the Bendixen positive range. Approximately one in every twenty trypanosome negative samples had lymphocyte numbers in the Bendixen positive range. Evidence indicated that trypanosome isolation from animals with lymphocytosis was not caused by increased numbers of infected buffy coat cells in the inoculum cultured. Eight calves were inoculated intravenously with trypanosome-infected blood. Lymphocyte numbers increased an average of 3549 per cumm above pre-inoculation levels in seven and remained essentially unchanged in one. Prior to inoculation with infective blood, two of the calves were intravenously inoculated with trypanosome-infected blood that had been frozen and thawed to kill the trypanosomes contained in it. Neither developed lymphocytosis following this inoculation. No clinical disease problems which could be attributed to trypanosome infection were found.